                               SEQUENCE LISTING

<110> THE UNIVERSITY OF TOLEDO
 
<120> MONOCLONAL IGM ANTIBODIES FROM ENTIRELY CARBOHYDRATE CONSTRUCTS

<130> 53-58415/D2015-13

<140>
<141>

<150> 62/396,603
<151> 2016-09-19

<160> 18     

<170> PatentIn version 3.5

<210> 1
<211> 318
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide


<220>
<221> CDS
<222> (1)..(318)

<400> 1
caa att gtt ctc acc cag tct cca gca atc atg tct gca tct cca ggg         48
Gln Ile Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly           
1               5                   10                  15                

gag aag gtc acc atg acc tgc agt gcc agc tca agt gta agt tac atg         96
Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met           
            20                  25                  30                    

cac tgg tac cag cag aag tca ggc acc tcc ccc aaa aga tgg att tat        144
His Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr           
        35                  40                  45                        

gac aca tcc aaa ctg gct tct gga gtc cct gct cgc ttc agt ggc agt        192
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser           
    50                  55                  60                            

ggg tct ggg acc tct tac tct ctc aca atc agc agc atg gag gct gaa        240
Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu           
65                  70                  75                  80            

gat gct gcc act tat tac tgc cag cag tgg agt agt aac ccg ctc acg        288
Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Leu Thr           
                85                  90                  95                

ttc ggt gct ggg acc aag ctg gag ctg aaa                                318
Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys                                   
            100                 105                                       


<210> 2
<211> 348
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide


<220>
<221> CDS
<222> (1)..(348)

<400> 2
cag atc cag ttg gta cag tct gga cct gag ctg aag aag cct gga gag         48
Gln Ile Gln Leu Val Gln Ser Gly Pro Glu Leu Lys Lys Pro Gly Glu           
1               5                   10                  15                

aca gtc aag atc tcc tgc aag gct tct ggg tat acc ttc aca acc tat         96
Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr           
            20                  25                  30                    

gga atg agc tgg gtg aaa cag gct cca gga aag ggt tta aag tgg atg        144
Gly Met Ser Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys Trp Met           
        35                  40                  45                        

ggc tgg ata aac acc tac tct gga gtg cca aca tat gct gat gac ttc        192
Gly Trp Ile Asn Thr Tyr Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe           
    50                  55                  60                            

aag gga cgg ttt gcc ttc tct ttg gaa acc tct gcc agc act gcc tat        240
Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Ser Thr Ala Tyr           
65                  70                  75                  80            

ttg cag atc aac aac ctc aaa aat gag gac acg gct aca tat ttc tgt        288
Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr Phe Cys           
                85                  90                  95                

gca aga cat tac tac gga ggg gct tac tgg ggc caa ggg act ctg gtc        336
Ala Arg His Tyr Tyr Gly Gly Ala Tyr Trp Gly Gln Gly Thr Leu Val           
            100                 105                 110                   

act gtc tct gca                                                        348
Thr Val Ser Ala                                                           
        115                                                               


<210> 3
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Gln Ile Gln Leu Val Gln Ser Gly Pro Glu Leu Lys Lys Pro Gly Glu 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Lys Gln Ala Pro Gly Lys Gly Leu Lys Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Tyr Ser Gly Val Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  


Lys Gly Arg Phe Ala Phe Ser Leu Glu Thr Ser Ala Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Ile Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr Phe Cys 
                85                  90                  95      


Ala Arg His Tyr Tyr Gly Gly Ala Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ala 
        115     


<210> 4
<211> 106
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Gln Ile Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              


Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu 
65                  70                  75                  80  


Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Leu Thr 
                85                  90                  95      


Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys 
            100                 105     


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Pro Thr Thr Thr Pro Leu Lys 
1               5           


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Pro Pro Thr Thr Thr Thr Lys Lys Pro 
1               5                   


<210> 7
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Gly Thr Thr Pro Ser Pro Val Pro Thr Thr Ser Thr Thr Ser Ala Pro 
1               5                   10                  15      


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Pro Thr Thr Asp Ser Thr Thr Pro Ala Pro Thr Thr Lys 
1               5                   10              


<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Thr Ser Ala Pro Asp Thr Arg Asp Ala Pro 
1               5                   10  


<210> 10
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Ala Pro Gly Ser Thr Ala Pro Pro 
1               5               


<210> 11
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gly Ala Lys Cys Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Thr Thr 
1               5                   10                  15      


Thr Gly 
        


<210> 12
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Lys Thr Thr Thr 
1               


<210> 13
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Lys Thr Thr Thr Gly 
1               5   


<210> 14
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Lys Pro Val Pro Ser Thr Pro Pro Thr Pro Ser Cys 
1               5                   10          


<210> 15
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Lys Pro Ser Thr Pro Pro Thr Pro Ser Pro Ser Cys 
1               5                   10          


<210> 16
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Lys Thr Pro Pro Thr Pro Ser Pro Ser Thr Pro Cys 
1               5                   10          


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Lys Pro Thr Pro Ser Pro Ser Thr Pro Pro Thr Cys 
1               5                   10          


<210> 18
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Lys Pro Ser Pro Ser Thr Pro Pro Thr Pro Ser Cys 
1               5                   10          

